FLEURY, I.; LAVERDURE, E. Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma. Canadian Hematology Today, Toronto, Canada, v. 2, n. 3, p. 5–11, 2023. DOI: 10.58931/cht.2023.2338. Disponível em: https://canadianhematologytoday.com/article/view/2-3-fleury_laverdure. Acesso em: 15 may. 2024.